NBA All-Star Amar'e Stoudemire Joins NOVODX Advisory Board to Advance Affordable, Accessible Preventive Healthcare

JUPITER, Fla., Aug. 29, 2025 /PRNewswire/ -- NOVODX Corporation a leader in next-generation at-home and point-of-care at home lab-testing, today announced that six-time NBA All-Star and entrepreneur Amar'e Stoudemire has joined its Advisory Board. Stoudemire will lend his influence, network, and passion for wellness to help accelerate NOVODX's mission of making reliable, affordable preventive healthcare at home testing available to everyone.

At the center of NOVODX's innovation is the GoldN Reader*, a portable at home testing platform. The GoldN Reader™ is being designed to provide rapid, on-site results in under 15 minutes, with the goal of eliminating the need to ship samples to a laboratory. The platform is intended to support a broad menu of tests, including women's health, fertility, infectious diseases, oncology, micronutrient analysis, and preventive screenings. By enabling access to timely information, the GoldN Reader™ aims to help bridge the gap between early detection and action, assisting in better outcomes.

"Access to reliable, timely health information changes lives," said Amar'e Stoudemire. "I'm proud to join NOVODX in bringing powerful tools like the GoldN Reader into communities everywhere, so people can take control of their health before problems become critical."

Stoudemire, known for his standout NBA career with the Phoenix Suns, New York Knicks, and Miami Heat, has built a diverse business portfolio spanning sports, wellness, and philanthropy. His commitment to holistic health aligns with NOVODX's focus on empowering individuals and communities to proactively manage their well-being.

"Amar'e Stoudemire's leadership, vision, and personal dedication to health makes him an invaluable voice on our Advisory Board," said Nancy Torres, CEO of NOVODX. "We share a belief that healthcare should be equitable, convenient, and informed; and that innovation should serve people, not the other way around."

NOVODX is currently expanding the GoldN Reader's test menu and preparing for market Launch Q1 of 2026, with the goal of transforming the way healthcare data for informed decisions is delivered and accessed.

About NOVODX

NOVODX is a health technology company developing solutions intended to bring advanced at home testing closer to patients. Say goodbye to shipping a box, truly at home testing finally. With an initial focus on women's health, fertility, infectious disease, oncology markers, and micronutrients, the NOVDX platform is being designed to empower users with access to timely actionable health information.

Leveraging an AI-powered app, the platform aims to provide results that are easy to interpret and securely share with a user's healthcare provider in a HIPAA-compliant manner. NOVODX's mission is to support early detection and accessible care through innovative, user-centered technology.

*The NOVODX Reader is currently under development and not yet offered for sale.

Media Contact:
Nancy Torres, CEO
NovoDX Corporation
646-957-2865
[email protected]
www.novo-dx.com

SOURCE NOVODX Corporation